Clinical trial
A Study of LY2605541 in Participants With Type 1 Diabetes Mellitus
NCT01792284
Study timeline
Study start (unknown)2013-02-01Date precision: month
Registry last updated2018-04-20
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Type 1 Diabetes Mellitusunresolved
Interventions
LY2605541DRUG
Insulin LisproDRUG · verified · RxNorm: insulin lispro
Sponsors & collaborators
Eli Lilly and Companylead sponsor
Mapped research locations
DallasTexas, United States1AuroraColorado, United States1Oklahoma CityOklahoma, United States1AustinTexas, United States1LexingtonKentucky, United States1FresnoCalifornia, United States1ChattanoogaTennessee, United States1Des MoinesIowa, United States1TopekaKansas, United States1GreerSouth Carolina, United States1TustinCalifornia, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01792284 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.